﻿<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.google.com/schemas/sitemap/0.84" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.google.com/schemas/sitemap/0.84 http://www.google.com/schemas/sitemap/0.84/sitemap.xsd">
  <url>
    <loc>http://nexavar.legalview.com/news-articles/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/urotoday-login/1277557/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/md-news-american-society-of-clinical-oncologys-gastrointestinal-cancer/1277556/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/complete-response-for-advanced-liver-cancer-during-sorafenib-therapy-c/1277555/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/arch-dermatol-sign-in-page/1277554/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/aveo-pharmaceuticals-nasdaq-aveo-posts-large-volume-increase-hits-1434/1277553/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/interesting-biotech-picks-for-2011-seeking-alpha/1277552/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/nci-cancer-bulletin-for-january-25-2011-national-cancer-institute/1277551/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/extracerebral-metastases-determine-the-outcome-of-patients-with-brain/1233412/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/urotoday-please-login-biomarkers-predicting-outcome-in-patients-with-a/1233411/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/urotoday-please-login-treatment-outcomes-of-sorafenib-for-first-line-o/1233410/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/macmillans-response-to-nice-decision-on-liver-cancer-drug/1233409/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/urotoday-please-login-long-term-safety-of-sorafenib-in-advanced-renal/1233408/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/urotoday-please-login-sorafenib-in-metastatic-renal-cell-carcinoma-wit/1233407/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/battling-cancer/1233406/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/owing-to-increased-access-to-medical-care-and-a-growing-drug-treated-p/1233405/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/onyx-pharmaceuticals-announces-carfilzomib-development-and-commerciali/1233404/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/melanoma-treatment-can-be-drawn-from-gene-mutation-topnews-united-stat/1195413/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/this-week-in-science-the-daily-scan-genomeweb/1195412/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/onyx-expects-to-file-myeloma-drug-at-fda-this-year/1195411/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/expresscouk-home-of-the-daily-and-sunday-express-uk-news-cash-delay-fo/1195410/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/news-sorafenib-provides-safe-long-lasting-control-in-older-patients-wi/1157692/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/benefit-not-seen-from-adding-sorafenib-in-lung-cancer-nsclc-study-pati/1157691/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/urotoday-carbonic-anhydrase-ix-and-pathological-features-as-predictors/1157690/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/living-with-melanoma-the-rolling-of-toilet-paper-and-health-care-artic/1157689/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/multiple-agent-therapy-with-metronomic-xeloda-and-nexavar-promising-fo/1157688/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/meta-analysis-sunitinib-sorafenib-increased-risk-for-arterial-thrombos/1157687/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/how-do-you-put-a-price-on-pain-abt-bsx-isrg-jnj-mdt-onxx-pfe/1157686/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://nexavar.legalview.com/news-articles/mesothelioma-blog-raquo-blog-archive-raquo-potential-for-cancer-cell-e/1157685/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
</urlset>
